[1]
“Beyond Black-Letter Antitrust: Pharmaceutical Patent Expiry, GenericCompetition, and the Rule of Reason in the Pfizer-Dexa Amlodipine Case a Comparative Legal-Systemic Study of Indonesia, the United States, the European Union, and Japan”, ajosh, vol. 4, no. 9, pp. 4507–4513, Jun. 2026, doi: 10.59888/ajosh.v4i9.747.